Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-16 Sale | 2023-03-20 6:43 pm | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 4,257 | $1.979 | $8,425 | 58,433 (Direct) | View |
| 2022-07-20 Sale | 2022-07-21 4:11 pm | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 7,463 | $1.422 | $10,612 | 62,690 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-15 Tax Withholding | 2024-11-19 8:02 pm | N/A N/A | EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | 27,224 | $35.05 | 294,897 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 6:59 pm | N/A N/A | EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | 82,121 | $0 | 322,121 (Direct) | View |
| 2023-08-24 Option Award | 2023-08-25 7:40 pm | 2024-08-24 2030-08-23 | EXELIXIS INC. | EXEL | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-07-19 Option Award | 2022-07-21 4:11 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 20,000 | $0 | 62,690 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-04 4:53 pm | N/A 2032-02-01 | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 240,000 | $0 | 246,421 (Direct) | View |
| 2021-10-24 Option Award | 2021-10-26 4:26 pm | N/A 2031-10-23 | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2021-05-31 Option Award | 2021-06-08 1:07 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 3,320 | $6.086 | 6,421 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 5:07 pm | N/A 2031-02-25 | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2020-11-30 Option Award | 2020-12-07 4:59 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 3,101 | $6.392 | 3,101 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 6:38 pm | N/A 2030-02-13 | CytomX Therapeutics Inc. | CTMX | Peterson Amy C. EVP, Chief Development Officer | 25,000 | $0 | 25,000 (Direct) | View |